Project Details
Description
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared with Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/18 → 10/31/22 |
Funding
- THE EMMES CORPORATION
- TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.